Furman Jennifer L, Sompol Pradoldej, Kraner Susan D, Pleiss Melanie M, Putman Esther J, Dunkerson Jacob, Mohmmad Abdul Hafiz, Roberts Kelly N, Scheff Stephen W, Norris Christopher M
Department of Pharmacology and Nutritional Sciences.
Sanders-Brown Center on Aging, and.
J Neurosci. 2016 Feb 3;36(5):1502-15. doi: 10.1523/JNEUROSCI.1930-15.2016.
Increasing evidence suggests that the calcineurin (CN)-dependent transcription factor NFAT (Nuclear Factor of Activated T cells) mediates deleterious effects of astrocytes in progressive neurodegenerative conditions. However, the impact of astrocytic CN/NFAT signaling on neural function/recovery after acute injury has not been investigated extensively. Using a controlled cortical impact (CCI) procedure in rats, we show that traumatic brain injury is associated with an increase in the activities of NFATs 1 and 4 in the hippocampus at 7 d after injury. NFAT4, but not NFAT1, exhibited extensive labeling in astrocytes and was found throughout the axon/dendrite layers of CA1 and the dentate gyrus. Blockade of the astrocytic CN/NFAT pathway in rats using adeno-associated virus (AAV) vectors expressing the astrocyte-specific promoter Gfa2 and the NFAT-inhibitory peptide VIVIT prevented the injury-related loss of basal CA1 synaptic strength and key synaptic proteins and reduced the susceptibility to induction of long-term depression. In conjunction with these seemingly beneficial effects, VIVIT treatment elicited a marked increase in the expression of the prosynaptogenic factor SPARCL1 (hevin), especially in hippocampal tissue ipsilateral to the CCI injury. However, in contrast to previous work on Alzheimer's mouse models, AAV-Gfa2-VIVIT had no effects on the levels of GFAP and Iba1, suggesting that synaptic benefits of VIVIT were not attributable to a reduction in glial activation per se. Together, the results implicate the astrocytic CN/NFAT4 pathway as a key mechanism for disrupting synaptic remodeling and homeostasis in the hippocampus after acute injury.
Similar to microglia, astrocytes become strongly "activated" with neural damage and exhibit numerous morphologic/biochemical changes, including an increase in the expression/activity of the protein phosphatase calcineurin. Using adeno-associated virus (AAV) to inhibit the calcineurin-dependent activation of the transcription factor NFAT (Nuclear Factor of Activated T cells) selectively, we have shown that activated astrocytes contribute to neural dysfunction in animal models characterized by progressive/chronic neuropathology. Here, we show that the suppression of astrocytic calcineurin/NFATs helps to protect synaptic function and plasticity in an animal model in which pathology arises from a single traumatic brain injury. The findings suggest that at least some astrocyte functions impair recovery after trauma and may provide druggable targets for treating victims of acute nervous system injury.
越来越多的证据表明,钙调神经磷酸酶(CN)依赖性转录因子NFAT(活化T细胞核因子)在进行性神经退行性疾病中介导星形胶质细胞的有害作用。然而,星形胶质细胞CN/NFAT信号对急性损伤后神经功能/恢复的影响尚未得到广泛研究。通过在大鼠中使用控制性皮质撞击(CCI)程序,我们发现创伤性脑损伤与损伤后7天海马中NFAT1和NFAT4活性增加有关。NFAT4而非NFAT1在星形胶质细胞中表现出广泛的标记,并在CA1和齿状回的轴突/树突层中均有发现。使用表达星形胶质细胞特异性启动子Gfa2和NFAT抑制肽VIVIT的腺相关病毒(AAV)载体阻断大鼠星形胶质细胞的CN/NFAT途径,可防止损伤相关的基底CA1突触强度和关键突触蛋白的丧失,并降低诱导长期抑郁的易感性。结合这些看似有益的作用,VIVIT治疗使促突触形成因子SPARCL1(hevin)的表达显著增加,尤其是在CCI损伤同侧的海马组织中。然而,与先前关于阿尔茨海默病小鼠模型的研究不同,AAV-Gfa2-VIVIT对GFAP和Iba1水平没有影响,这表明VIVIT的突触益处并非归因于胶质细胞活化本身的减少。总之,这些结果表明星形胶质细胞CN/NFAT4途径是急性损伤后破坏海马突触重塑和稳态的关键机制。
与小胶质细胞类似,星形胶质细胞在神经损伤时会强烈“活化”,并表现出许多形态学/生化变化,包括蛋白磷酸酶钙调神经磷酸酶的表达/活性增加。通过使用腺相关病毒(AAV)选择性抑制转录因子NFAT(活化T细胞核因子)的钙调神经磷酸酶依赖性活化,我们已经表明活化的星形胶质细胞在以进行性/慢性神经病理学为特征的动物模型中介导神经功能障碍。在这里,我们表明在因单次创伤性脑损伤而出现病理变化的动物模型中,抑制星形胶质细胞钙调神经磷酸酶/NFAT有助于保护突触功能和可塑性。这些发现表明,至少某些星形胶质细胞功能会损害创伤后的恢复,并且可能为治疗急性神经系统损伤的受害者提供可药物作用的靶点。